ELAVL1 and cancer: Various compounds and small molecules, such as CMLD-2, KH-3, and Dihydrotanshinone I (DHTS), have been identified as effective inhibitors of the HuR-RNA interaction, offering promising therapeutic avenues for reducing the stability of oncogenic mRNAs and inhibiting cancer progression (Table 2).